Abstract
Full text available
Current Bioactive Compounds
Title: Anti-Depressant
Volume: 1 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Anti-Depressant, Current Bioactive Compounds 2005; 1 (3) . https://dx.doi.org/10.2174/157340705774932998
DOI https://dx.doi.org/10.2174/157340705774932998 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
OCD or not OCD? A Critical Evaluation of the Obsessive Compulsive Related Disorders
Current Psychiatry Reviews 31P NMR Spectroscopy of Phospholipids: From Micelles to Membranes
Current Analytical Chemistry Meet Our Editorial Board Member:
Current Psychiatry Reviews Is Longevity a Heritable Trait? Evidence for Non-genomic Influence from an Extended Longevity Phenotype of Drosophila melanogaster
Current Aging Science An Updated Overview of The Complex Clinical Spectrum of Tourette Syndrome
Current Drug Therapy Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
Current Medicinal Chemistry Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients
Current HIV Research Protonation States in Molecular Dynamics Simulations of Peptide Folding and Binding
Current Pharmaceutical Design Wnt/β-Catenin Signaling in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
CNS & Neurological Disorders - Drug Targets Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction
Current Drug Abuse Reviews Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Computational Methods for DNA-binding Protein and Binding Residue Prediction
Protein & Peptide Letters Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism The Role of Placental Carbonyl Reducing Enzymes in Biotransformation of Bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone
Drug Metabolism Letters Synaptic Plasticity in Drug Reward Circuitry
Current Molecular Medicine Impact of Apolipoprotein E on Alzheimer’s Disease
Current Alzheimer Research The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design PSEN1 Promoter Demethylation in Hyperhomocysteinemic TgCRND8 Mice is the Culprit, not the Consequence
Current Alzheimer Research